Prosper as a Cross-Cultural Company by Providing Leading Edge Healthcare Technologies, Quality Products and Services to China’s Professional Communities with Pride.
Chindex was founded in 1981 by Roberta Lipson and Elyse Beth Silverberg, two young American women who had moved to China in the late 1970s, following re-establishment of diplomatic and commercial relations between the US and China, to establish a cross-cultural bridge in the early days of China’s commercial opening to the West. Their vision was to bring all varieties of advanced Western healthcare technologies to China and provide excellent customer service to buyers and suppliers alike. Their motivation went well beyond the bottom line, to improving the lives of Chinese people.
Chindex has undergone many transitions and adaptations over its 30-year history, but has always stayed true to this vision, and has led the Company to what it has become today: the premier American healthcare company in China.
Chindex operates in two healthcare businesses. Premium health care services are provided through its renowned United Family Healthcare (UFH) brand, while Chindex Medical Limited (CML) delivers marketing, distribution and service of medical capital equipment and instrumentation through a deeply experienced team.
United Family Healthcare is the Company’s world-class hospital network in China. All UFH hospitals and clinics provide patients with the very best in premium health care in a highly personalized setting, with more attention paid to individuals by our expert staff than can often be found in medical facilities elsewhere in Asia or the West.
Beijing United Family Hospital (BJU), the first UFH hospital, commenced operations in 1997, and is still the only facility of its kind in Beijing. It provides comprehensive inpatient and outpatient medical care with internationally board-certified Western doctors as well as the most skilled Chinese doctors coming from Beijing’s top hospitals. All medical and support staff at BJU are English speaking and are among the most experienced medical teams found anywhere. UFH operations in Shanghai commenced services in 2004 with the opening of Shanghai United Family Hospital (SHU), providing an unmatched level of quality and service in that global city, generally including all the services, amenities, and capabilities found in Beijing. In accordance with Chinese regulations governing foreign-invested healthcare facilities, both UFH hospitals are contractual joint ventures with local Chinese partners.
UFH facilities in Beijing and Shanghai currently provide full-service premium inpatient and outpatient medical care with 5 satellite clinics in Beijing and 2 satellite clinics in Shanghai. Among the clinics in Beijing, the United Family New Hope Oncology Center, opened in 2011 and housed in China’s first medical facility built to US LEED environmental standards on the side of a park, gives China the first of its kind multidisciplinary team approach to treating cancer in a uniquely relaxed setting, so that patients can focus on a better quality of life. As well, the United Family managed International Division at Huashan Pudong Hospital marks China’s first such cooperative service offering between China’s leading public and premier private hospitals. Chindex expanded into its third major market with the opening of a clinic in Guangzhou in 2009, and is further expanding operations in that southern Chinese city with construction commencing on UFH’s largest full-service hospital yet.. Construction is also currently underway in the eastern city of Tianjin, China’s fastest emerging economic zone, on Tianjin United Family Hospital (TJU), introducing a whole new level of service to this region. In addition, UFH provides management services to a clinic in Wuxi, a major metropolitan area close to Shanghai.
Chindex is a recognized pioneer in the field of private healthcare services in China, and continues to introduce new paradigms in the industry, as in September 2006 when UFH announced the first premium commercial health insurance product available to Chinese nationals in China. The insurance product plan was developed by FESCO IB Insurance Brokerage Company Ltd. and utilizes UFH’s hospital and clinic network as its preferred medical service provider. In addition, in 2005, Beijing United Family Hospital and Clinics was the first integrated health system in Asia to receive accreditation by the Joint Commission International (JCI), the worldwide leader in improving the quality of healthcare. UFH operations in Shanghai received similar accreditation in 2008, placing UFH’s multi-city healthcare network, the only one of its kind in China, in an elite group of the world’s best healthcare providers with the JCI ‘Gold Seal of Approval.
The demand for international-standard healthcare services in China continues to increase due to a growing Chinese upper-middle class and the influx of Western people, influences and concepts, along with the mounting ability of Chinese citizens to afford better healthcare services. The liberalization of the insurance industry will provide expanded access to health insurance products for Chinese citizens allowing more access to premium healthcare services such as UFH.
As the leading private hospital corporation in China, Chindex plans to continue its growth in healthcare services through expansion of the UFH network. Market expansion plans are underway in each geographic market. In Beijing, service offerings will be significantly expanded during 2010 through tripling the size and doubling the bed count of the existing hospital campus, as well as the opening of additional affiliated clinics. In Shanghai, expansion projects are expected to include increased services at the current hospital campus as well as at the United Family managed clinic in Pudong, and the opening of additional facilities over the coming years. In Guangzhou, the clinic will continue to expand its service offerings while the full service hospital is expected to open soon. The new and expanded facilities in Guangzhou and Beijing, respectively, will be several times larger than the current facilities in Beijing and Shanghai, targeting the growing segment of affluent Chinese families in the major urban centers in China.
Since the Company’s founding in 1981, Chindex has been active in the marketing, distribution and service of medical capital equipment and instrumentation in mainland China, expanding to include Hong Kong in the mid-1990s.
Beginning in 2011, Chindex and Fosun Pharma, the largest private medical and pharmaceutical enterprise in China, have formed a strategic alliance in the medical device industry. Chindex Medical Limited (CML) is a joint venture company, of which Chindex owns 49% equity, but which maintains the Chindex name and logo, as they have come to symbolize the very best products and services and a strong commitment to customer service.
In addition to providing full-service distribution services in China to manufacturers of high-end medical devices, Chindex Medical Limited’s businesses also engage in R&D, manufacturing, distribution and export of Chinese devices and consumables, including blood transfusion consumables and viral inactivation systems, surgical consumables, and dental products and materials.